TrialLancet (London, England)2022

Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.

Stacie M Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.